Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma
Clinical trial NCT00276679 · COMPLETED
Trial details
- NCT number
- NCT00276679
- Sponsor
- Children's Cancer and Leukaemia Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.